Skip to content

Clinical trials

Observational Multiple Myeloma trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Phase: Observational Country / region: United Kingdom Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20101
20121
20141
20161
20172
20192
20203
20214
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting4
Unknown status3
Active, not recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene2
Institute of Cancer Research, United Kingdom2
Janssen-Cilag Ltd.2
Bristol-Myers Squibb1
Gruppo Italiano Malattie EMatologiche dell'Adulto1
Janssen Pharmaceutica N.V., Belgium1
Royal Marsden NHS Foundation Trust1
Sandoz1
Sanofi1
Sheffield Teaching Hospitals NHS Foundation Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma18
Breast Neoplasms1
COVID-191
Coronavirus Infections1
Febrile Neutropenia1
Lung Neoplasms1
Lymphoma, B-Cell1
Neoplasms1
Ovarian Neoplasms1
Pain1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.